Sunshine Biopharma Inc.’s Q3 2026 10-Q window runs Nov 9, 2026 to Nov 19, 2026.
Based on 8 prior 10-Q filings.
Sunshine Biopharma Inc. · CIK 1402328 · Engraved from SEC EDGAR